• Login
Saturday, October 10, 2026
Geneva Times Tamil
  • Home
  • Editorial
  • Switzerland
  • Europe
  • International
  • Un
  • Business
  • Sports
  • More
    • Article
    • Tamil
No Result
View All Result
  • Home
  • Editorial
  • Switzerland
  • Europe
  • International
  • Un
  • Business
  • Sports
  • More
    • Article
    • Tamil
No Result
View All Result
Geneva Times Tamil
No Result
View All Result
  • Home
  • Editorial
  • Switzerland
  • Europe
  • International
  • Un
  • Business
  • Sports
  • More
Home International

What happened in the failed execution of Christa Pike – and what next?

GenevaTimes by GenevaTimes
October 2, 2026
in International
Reading Time: 1 min read
0
What happened in the failed execution of Christa Pike – and what next?
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter


The Tennessee correction department said Pike had been taken to an off-site medical facility, while one of her lawyers said on Wednesday that she was being given “life-saving measures” in hospital.

On Thursday, lawyer Randy Spivey told reporters: “We don’t have a sense of her prognosis or much update on her health at the moment.”

Dr Joel Zivot, a professor at the Emory University School of Medicine, told the BBC in an email: “It’s very possible that as a consequence of the delay of the beginning of resuscitation she [Pike] will have a brain injury.”

Pike’s lawyers are now asking for her sentence to be commuted, but it is not clear what might happens next.

Historically, the US Supreme Court has not halted second attempts at executions, said John Mills, a lawyer who works with inmates sentenced to death.

In 2024, it allowed Alabama to proceed with a second execution of Kenneth Eugene Smith, using an experimental oxygen deprivation method, after their attempt to kill him by lethal injection failed two years earlier.

Read More

Previous Post

Penn State vs. Northwestern Prediction, Odds, Pick For College Football Week 5

Next Post

Biogen reports 52-week litifilimab data for lupus treatment

Next Post
Biogen reports 52-week litifilimab data for lupus treatment

Biogen reports 52-week litifilimab data for lupus treatment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Facebook Twitter Instagram Youtube LinkedIn

Explore the Geneva Times

  • About us
  • Contact us

Advertise with us:

marketing@genevatimes.ch

Contact us:

editor@genevatimes.ch

Visit us

© 2023 -2024 Geneva Times| Desgined & Developed by Immanuel Kolwin

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Editorial
  • Switzerland
  • Europe
  • International
  • Un
  • Business
  • Sports
  • More
    • Article
    • Tamil

© 2023 -2024 Geneva Times| Desgined & Developed by Immanuel Kolwin